MoneyWorks4Me

Anuh Pharma - Quaterly Results

05 Aug 2022 Evaluate
Revenue showed a marginal decline at Rs. 1163.77 millions. For the quarter ended June 2022, as compared to corresponding quarter of last year.Good  Net Profit growth of 31.19% reported above the corresponding previous quarter figure of Rs. 55.91 millions to Rs. 73.35 millioins.Operating profit for the quarter ended June 2022 rose to 121.40 millions as compared to 102.82 millions of corresponding quarter ended June 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 1163.77 1172.72 -0.76 1163.77 1172.72 -0.76 4866.46 4319.60 12.66
Other Income 9.55 19.24 -50.36 9.55 19.24 -50.36 51.97 105.38 -50.68
PBIDT 121.40 102.82 18.07 121.40 102.82 18.07 520.43 551.22 -5.59
Interest 0.60 1.76 -65.91 0.60 1.76 -65.91 9.61 14.94 -35.68
PBDT 120.80 101.06 19.53 120.80 101.06 19.53 510.82 536.28 -4.75
Depreciation 24.18 29.91 -19.16 24.18 29.91 -19.16 119.60 150.76 -20.67
PBT 96.62 71.15 35.80 96.62 71.15 35.80 391.22 385.52 1.48
TAX 23.27 15.24 52.69 23.27 15.24 52.69 85.61 101.15 -15.36
Deferred Tax -1.33 -2.16 -38.43 -1.33 -2.16 -38.43 -9.95 6.50 -253.08
PAT 73.35 55.91 31.19 73.35 55.91 31.19 305.61 284.37 7.47
Equity 250.56 250.56 0.00 250.56 250.56 0.00 250.56 250.56 0.00
PBIDTM(%) 10.43 8.77 18.98 10.43 8.77 18.98 10.69 12.76 -16.20
Peers
Company Name CMP
Sun Pharma. Inds. 1833.80
Dr. Reddys Labs. 1167.15
Cipla 1356.00
Lupin 2081.00
Zydus Lifesciences 1113.85
View more..